STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters
Boudewijns, R.; Thibaut, H. J.; Kaptein, S. J. F.; Li, R.; Vergote, V.; Seldeslachts, L.; De Keyzer, C.; Sharma, S.; Jansen, S.; Van Weyenbergh, J.; Ma, J.; Martens, E.; Bervoets, L.; Van Buyten, T.; Jacobs, S.; Liu, Y.; Marti-Carreras, J.; Vanmechelen, B.; Wawina-Bokalanga, T.; Delang, L.; Rocha-Pereira, J.; Coelmont, L.; Chiu, W.; Leyssen, P.; Heylen, E.; Schols, D.; Wang, L.; Close, L.; Matthijnssens, J.; Van Ranst, M.; Schramm, G.; Van Laere, K.; Opdenakker, G.; Maes, P.; Weynand, B.; Cawthorne, C.; Vande Velde, G.; Wang, Z.; Neyts, J.; Dallmeier, K.
Show abstract
Introductory paragraphSince the emergence of SARS-CoV-2 causing COVID-19, the world is being shaken to its core with numerous hospitalizations and hundreds of thousands of deaths. In search for key targets of effective therapeutics, robust animal models mimicking COVID-19 in humans are urgently needed. Here, we show that productive SARS-CoV-2 infection in the lungs of mice is limited and restricted by early type I interferon responses. In contrast, we show that Syrian hamsters are highly permissive to SARS- CoV-2 and develop bronchopneumonia and a strong inflammatory response in the lungs with neutrophil infiltration and edema. Moreover, we identify an exuberant innate immune response as a key player in pathogenesis, in which STAT2 signaling plays a dual role, driving severe lung injury on the one hand, yet restricting systemic virus dissemination on the other. Finally, we assess SARS-CoV- 2-induced lung pathology in hamsters by micro-CT alike used in clinical practice. Our results reveal the importance of STAT2-dependent interferon responses in the pathogenesis and virus control during SARS-CoV-2 infection and may help rationalizing new strategies for the treatment of COVID-19 patients.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates 98%
- A basally active cGAS-STING pathway limits SARS-CoV-2 replication in a subset of ACE2 positive airway cell models 97%
- A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions 97%
Similar papers in this journal
- ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology 96%
- Dual signaling via interferon and DNA damage response elicits entrapment by giant PML nuclear bodies 96%
- Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains 95%
Similar papers in this journal
- Murine Parainfluenza Virus Persists in Lung Innate Immune Cells Sustaining Chronic Lung Pathology 97%
- SARS-CoV-2 infection leads to acute infection with dynamic cellular and inflammatory flux in the lung that varies across nonhuman primate species 96%
- Viral evolution prediction identifies broadly neutralizing antibodies against existing and prospective SARS-CoV-2 variants 96%
Similar papers in this journal
- IFN-γ primes bone marrow neutrophils to acquire regulatory functions in severe viral respiratory infections 96%
- Identification and Targeting of Regulators of SARS-CoV-2-Host Interactions in the Airway Epithelium. 96%
- Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies 95%
Similar papers in this journal
- Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility 97%
- A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures 96%
- Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity in uninfected and previously infected individuals 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.